-
Cleveland Clinic, AtlantiCare partner on cancer care
Cleveland Clinic Cancer Institute is partnering with Egg Harbor Township, N.J.-based AtlantiCare Cancer Institute to expand access to advanced research, clinical trials and cancer treatment for AtlantiCare patients. -
Funding for Cancer Moonshot nixed, but more left for grants: NCI director
The funding bill for the National Cancer Institute and the National Institutes of Health have been finalized, leaving the NCI with $96 million less than its fiscal year 2023 total enacted budget but $120 million more compared to the base budget. -
Aaron Rodgers gifts $3M to California cancer center
New York Jets quarterback Aaron Rodgers pledged $3 million toward Enloe Health's upcoming comprehensive cancer center in Chico, Calif., the Enterprise-Record reported April 9. -
Dana-Farber retracts 7th study after investigation
Boston-based Dana-Farber Cancer Institute has retracted an additional study in the midst of an investigation into research that may include manipulated or duplicated images, NBC News reported April 9. -
Study points to potential factor in rising cancer rates in younger adults
Accelerated biological aging may be a factor in rising cancer rates among younger adults, new findings from researchers at the Washington University School of Medicine in St. Louis suggest. -
New global cancer diagnoses to reach 35M by 2050: 5 new findings
By 2050, new cancer diagnoses are expected to reach 35 million worldwide — up from the 20 million cases diagnosed in 2022, according to the American Cancer Society's 2024 report on global cancer statistics. -
Only 43% of fast-tracked cancer drugs show benefits: Study
A recent study by researchers at Brigham and Women's Hospital and Harvard Medical School, both based in Boston, found only 43% of cancer drugs granted accelerated FDA approval demonstrated clinical benefit in confirmatory trials. -
Keck Medicine to test at-home immunotherapy for lung cancer
Los Angeles-based Keck Medicine of USC will assess the feasibility of providing home-based immunotherapy to patients with non-small cell lung cancer via a new clinical trial. -
20% of people with cancer participate in research: Fred Hutch study
In the U.S., 1 in 5 people with cancer participate in some form of clinical research, according to the first report to estimate participation levels across all types of cancer studies. -
Yale cancer leader heads to UAMS
The University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has named Yong Zhu, PhD, associate director for population science and translational science, the Little Rock-based organization said April 2. -
81% of oncologists say patients should consent to AI treatment before use
Approximately 81% of oncologists said patients should consent to artificial intelligence use for cancer treatment decisions, a recent survey found. -
Nursing group honors 5 for excellence in oncology
The Oncology Nursing Society honored five nurses and a cancer center for excellence. -
Fox Chase expands cancer care to New Jersey
Philadelphia-based Fox Chase Cancer Center has expanded to New Jersey with its first oncology office. -
ASCO issues vaccination guidelines for cancer patients
Making sure adults with cancer are up to date on recommended vaccinations should be a key part of their care to prevent or limit the severity of infections, the American Society of Clinical Oncology said in updated guidelines published March 18. -
NYU Langone's melanoma vaccine takes next step
New York City-based NYU Langone Health's Perlmutter Cancer Center launched a phase 3 trial for its metastasis melanoma mRNA vaccine. -
NYC Health + Hospitals takes cancer screening to 50,000 people's homes
New York City-based NYC Health + Hospitals screened more than 50,000 patients for colorectal cancer in 2023 using an at-home fecal immunochemical test. -
UAMS snags $11.5M for new cancer center
Little Rock-based University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute received an $11.48 million federal grant to create the Center for Molecular Interactions in Cancer. -
Surgeries for colon cancer took nearly 20% dip amid COVID
Research continues to uncover the significant ways in which COVID-19 has disrupted cancer care, with new findings showing colorectal cancer surgeries fell 17.3% in the first year of the pandemic. -
The underutilized test that could prevent chemo overdosing
A genetic test could stop some patients from overdosing on a chemotherapy drug, but only 3% of oncologists are testing patients, KFF Health News reported March 26. -
Kate Middleton's cancer diagnosis marks familiar scenario, oncologists say
In revealing a cancer diagnosis March 22, Kate Middelton said the cancer was detected following a surgical procedure — something oncologists say they encounter frequently.
Page 17 of 50